MediciNova
MNOV
34 hedge funds and large institutions have $12.4M invested in MediciNova in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 15 reducing their positions, and 8 closing their positions.
1,517% more call options, than puts
Call options by funds: $97K | Put options by funds: $6K
3% more capital invested
Capital invested by funds: $12.1M → $12.4M (+$326K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.42% less ownership
Funds ownership: 11.39% → 10.97% (-0.42%)
15% less funds holding
Funds holding: 40 → 34 (-6)
67% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 15
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$281K |
| 2 |
Citigroup
New York
|
+$111K |
| 3 |
BlackRock
New York
|
+$36.3K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$10.4K |
| 5 |
Renaissance Technologies
New York
|
+$5.51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$118K |
| 2 |
Jane Street
New York
|
-$113K |
| 3 |
E
Ergoteles
New York
|
-$84K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$70.9K |
| 5 |
Millennium Management
New York
|
-$68.8K |
MNOV Hedge Fund Activity: Q2 2023 in Review
34 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q2 2023, worth a combined $12.4M — up 2.7% from $12.1M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of MNOV and 2 opened new positions — a net loss of 6 holders — while 15 trimmed existing stakes and 5 added.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $281K. The largest seller was UBS Group, cutting an estimated $118K.
- 34 institutional investors held MediciNova (MNOV) as of Q2 2023, down from 40 in Q1 2023.
- Funds reported $12.4M of MediciNova stock for Q2 2023, up 2.7% quarter-over-quarter.
- 2 funds opened new MediciNova positions in Q2 2023 and 8 closed out, a net change of -6 holders.
- The largest MediciNova buyer in Q2 2023 was Bank of Montreal, an estimated $281K added.
- The largest MediciNova seller in Q2 2023 was UBS Group, an estimated $118K sold.
Based on aggregated 13F filings for Q2 2023.